TABLE 2.
Results of the RejuvenAir System Metered Cryospray study [29]
RCT | Subjects | Time point | Result | |
Quality of life | ||||
SGRQ total score change | No | 34 | 3 months | −6.4±14.4 |
No | 31 | 12 months | −4.6±15.1 | |
CAT total score change | No | 34 | 3 months | −3.8±7.1 |
No | 31 | 12 months | −2.0±7.2 | |
Chronic bronchitis symptoms | ||||
LCQ total score change | No | 34 | 3 months | 21.6±32.2 |
No | 31 | 12 months | 9.1±29.0 | |
Lung function | ||||
FEV1 mL change | No | 34 | 3 months | −33.2±167 |
No | 31 | 12 months | −96.5±198 | |
Exercise capacity | ||||
6MWD m change | No | 34 | 3 months | 1.1±55.4 |
No | 31 | 12 months | 8.5±76.2 |
Data are presented as n or mean±sd. Statistically significant values compared to baseline (p<0.05) are presented in bold. RCT: randomised controlled trial; SGRQ: St George's Respiratory Questionnaire; CAT: COPD Assessment Test; LCQ: Leicester Cough Questionnaire; FEV1: forced expiratory volume in 1 s; 6MWD: 6-min walk distance.